These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 34589089)
1. Astragaloside IV Alleviates the Experimental DSS-Induced Colitis by Remodeling Macrophage Polarization Through STAT Signaling. Tian L; Zhao JL; Kang JQ; Guo SB; Zhang N; Shang L; Zhang YL; Zhang J; Jiang X; Lin Y Front Immunol; 2021; 12():740565. PubMed ID: 34589089 [TBL] [Abstract][Full Text] [Related]
2. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of Platycodin D on dextran sulfate sodium (DSS) induced colitis and E. coli Lipopolysaccharide (LPS) induced inflammation. Guo R; Meng Q; Wang B; Li F Int Immunopharmacol; 2021 May; 94():107474. PubMed ID: 33611056 [TBL] [Abstract][Full Text] [Related]
4. Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype. Zhu W; Jin Z; Yu J; Liang J; Yang Q; Li F; Shi X; Zhu X; Zhang X Int Immunopharmacol; 2016 Jun; 35():119-126. PubMed ID: 27039210 [TBL] [Abstract][Full Text] [Related]
5. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition. Huai M; Zeng J; Ge W Int Immunopharmacol; 2021 Feb; 91():107284. PubMed ID: 33359851 [TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis. Liu Y; Liu X; Hua W; Wei Q; Fang X; Zhao Z; Ge C; Liu C; Chen C; Tao Y; Zhu Y Int Immunopharmacol; 2018 Apr; 57():121-131. PubMed ID: 29482156 [TBL] [Abstract][Full Text] [Related]
7. Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway. Huang C; Wang J; Liu H; Huang R; Yan X; Song M; Tan G; Zhi F BMC Med; 2022 Apr; 20(1):148. PubMed ID: 35422042 [TBL] [Abstract][Full Text] [Related]
8. Exploring a novel triptolide derivative possess anti-colitis effect via regulating T cell differentiation. Fu J; Zang Y; Zhou Y; Chen C; Shao S; Shi G; Wu L; Zhu G; Sun T; Zhang D; Zhang T Int Immunopharmacol; 2021 May; 94():107472. PubMed ID: 33611058 [TBL] [Abstract][Full Text] [Related]
9. Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization Lu Q; Li J; Ding P; Mao T; Shi L; Sun Z; Tan X; Jiang H; Dong J; Li Y; Yang X; Shi R Biomed Res Int; 2022; 2022():9427076. PubMed ID: 36060126 [TBL] [Abstract][Full Text] [Related]
10. Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way. Wu Y; Wu B; Zhang Z; Lu H; Fan C; Qi Q; Gao Y; Li H; Feng C; Zuo J; Tang W FASEB J; 2020 Jun; 34(6):8028-8043. PubMed ID: 32301543 [TBL] [Abstract][Full Text] [Related]
11. Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease. Martin-Rodriguez O; Gauthier T; Bonnefoy F; Couturier M; Daoui A; Chagué C; Valmary-Degano S; Gay C; Saas P; Perruche S Front Immunol; 2021; 12():754475. PubMed ID: 35003066 [TBL] [Abstract][Full Text] [Related]
12. Hong ZS; Xie J; Wang XF; Dai JJ; Mao JY; Bai YY; Sheng J; Tian Y Front Immunol; 2022; 13():924178. PubMed ID: 35911761 [TBL] [Abstract][Full Text] [Related]
13. Procyanidin improves experimental colitis by regulating macrophage polarization. Shi Y; Zhang H; Li S; Xin D; Li S; Yan B; Wang S; Liu C Biomed Pharmacother; 2023 Sep; 165():115076. PubMed ID: 37478578 [TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro. Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303 [TBL] [Abstract][Full Text] [Related]
15. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization. Lin Y; Yang X; Yue W; Xu X; Li B; Zou L; He R Cell Mol Immunol; 2014 Jul; 11(4):355-66. PubMed ID: 24727542 [TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory Mechanisms of Koreanaside A, a Lignan Isolated from the Flower of Kim TW; Shin JS; Chung KS; Lee YG; Baek NI; Lee KT Cells; 2019 Sep; 8(10):. PubMed ID: 31569788 [TBL] [Abstract][Full Text] [Related]
17. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier. Zhang X; Zhang F; Li Y; Fan N; Zhao K; Zhang A; Kang J; Lin Y; Xue X; Jiang X J Transl Med; 2024 Apr; 22(1):406. PubMed ID: 38689349 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of FABP5 attenuates inflammatory bowel disease by modulating macrophage alternative activation. Xu J; Zheng B; Xie C; Zhao Y; Wu H; Wang Y; Guan X; Lei X; Liu D; Lou X; Chen X; Huang Y Biochem Pharmacol; 2024 Jan; 219():115974. PubMed ID: 38081366 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis. Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J Front Immunol; 2020; 11():592084. PubMed ID: 33240279 [TBL] [Abstract][Full Text] [Related]
20. MANF ameliorates DSS-induced mouse colitis via restricting Ly6C Yang L; Shen WW; Shao W; Zhao Q; Pang GZ; Yang Y; Tao XF; Zhang WP; Mei Q; Shen YX Acta Pharmacol Sin; 2023 Jun; 44(6):1175-1190. PubMed ID: 36635421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]